Perrigo
 |
|
 |
|
| Public | |
| Traded as | : PRGO : PRGO S&P 500 Component |
| Industry | Pharmaceutical |
| Founded | 1887 |
| Headquarters |
|
|
Key people
|
John Hendrickson, Chairman, President and CEO |
| Products | OTC, RX, API, Medical Diagnostic, pharmaceuticals |
| Revenue |
 $3,540 million (2013) |
|
$805 million(2013) |
|
|
$ 530 million (2013) |
|
|
Number of employees
|
10,220 (May 2015) |
| Website | perrigo |
Perrigo Company plc is an American international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are traded on the NYSE and the ; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. Perrigo is the only non-Israeli company on the TA-25.
Perrigo Company plc, through its wholly owned subsidiaries, engages in the manufacture and sale of consumer healthcare products, generic prescription drugs, active pharmaceutical ingredients (API), and consumer products primarily in the United States, Australia, Israel, Europe, India and Mexico.
The L. Perrigo Company was founded in 1887 in Allegan, Michigan, by Luther and Charles Perrigo, who ran a country general store . In 1991 Perrigo had an Initial public offering on NASDAQ.
In March 2005 the firm acquired Agis Industries Ltd. (:AGIS), an Israel-based generic pharmaceuticals company in an $850 million transaction. Agis was founded in 1983 by Mori Arkin who developed his father's small drug import business into a multinational generic pharmaceutical company. As a result of the acquisition Arkin owns 9% of Perrigo, and was appointed as Vice Chairman of the company.
In April 2015, Perrigo received a buy-out offer from Mylan for a fee of $29 billion. In May 2016 Perrigo investors sued the company over misleading statements made during Mylans hostile takeover attempt. Those false statements are said to have persuaded shareholders to vote against the deal.
On 9 January 2008, the firm acquired Galpharm Healthcare, Ltd., a supplier of over-the-counter store brand pharmaceuticals in the United Kingdom. On 16 September 2008, the firm acquired J.B. Laboratories. On 6 October 2008, it acquired Laboratorios Diba S.A., enabling the company to market its products in Mexico. On 13 November 2008, it acquired Unico Holdings, a manufacturer of store brand pediatric electrolytes, enemas and feminine hygiene products for retail consumers in the U.S.
...
Wikipedia